Viewing StudyNCT04408118



Ignite Creation Date: 2024-05-06 @ 2:43 PM
Last Modification Date: 2024-10-26 @ 1:36 PM
Study NCT ID: NCT04408118
Status: COMPLETED
Last Update Posted: 2024-06-04
First Post: 2020-05-20

Brief Title: First Line Atezolizumab Paclitaxel and Bevacizumab Avastin in mTNBC
Sponsor: MedSIR
Organization: MedSIR

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Advanced Breast Cancer
Triple Negative Breast Cancer
Keywords:
Name View
HR negative View
breast cancer View
metastatic breast cancer View
triple negative breast cancer View
HER2 negative View